Headlines

MID WEB AD_Vertical left side 426 pixels (height) x 170 pixels (width).gif

FDA warns against using compounded semaglutide

The FDA has received adverse event reports after patients used compounded semaglutide for type 2 diabetes and weight loss. Drug...

FDA warns against using compounded semaglutide

AOMs help patients manage postsurgical weight recurrence

Anti-obesity medications, including semaglutide (Ozempic and Wegovy), can effectively help patients manage weight regained after...

FDA warns against using compounded semaglutide

Body contouring does not offer clinically significant, long-term sustained weight loss benefit

OASIS 1 trial: Oral semaglutide 50mg achieves 15.1% weight loss

Research

AOMs help patients manage postsurgical weight recurrence

Anti-obesity medications, including semaglutide (Ozempic and Wegovy), can effectively help patients manage weight regained after...

Obesity will become the most important risk factor for heart attacks

Researchers from the National University of Singapore have predicted that the number of heart attacks in Singapore is projected to rise...

FDA warns against using compounded semaglutide

The FDA has received adverse event reports after patients used compounded semaglutide for type 2 diabetes and weight loss. Drug...

Journal Watch 31/05/2023

Welcome to our weekly round-up of the latest bariatric and obesity-related papers published in the medical literature. As ever, we have...

Obesity increases risk of mental disorders

Obesity diagnosis significantly increases the probability of a broad spectrum of mental disorders in all age groups m- including...

Researchers design strategy to fight obesity through gene therapy

Researchers from the University of Barcelona and CIBERobn have designed a strategy to fight obesity and diabetes in mice through ex vivo...

Body contouring does not offer clinically significant, long-term sustained weight loss benefit

For patients with massive weight loss after bariatric surgery, subsequent body contouring to remove excess skin is not itself associated...

Olympus launches POWERSEAL Sealer/Divider, a next level surgical bipolar energy device in EMEA

Olympus has announced the full market launch of POWERSEAL Sealer/Divider for the Europe, Middle East and Africa (EMEA) region. This...

Journal watch 24/05/2023

Welcome to our weekly round-up of the latest bariatric and obesity-related papers published in the medical literature. As ever, we have...

B cells promote liver cancer with dangerous dual strategy

An increase in the numbers of activated B cells in the gastrointestinal tract drive inflammatory fatty liver disease (NASH, non-alcoholic...

Endotoxin fragments help drive obesity

Nottingham Trent University researchers have found that microbe fragments called endotoxin enter the blood stream and directly impact how...

OASIS 1 trial: Oral semaglutide 50mg achieves 15.1% weight loss

Headline results from OASIS 1 - a phase 3a 68-week, efficacy and safety trial comparing once-daily oral semaglutide 50 mg for weight...

Industry

Olympus launches POWERSEAL Sealer/Divider, a next level surgical bipolar energy device in EMEA

Fractyl initiates Global Registry Study of the Revita System

ReShape gains receives US patent for Obalon Balloon System

Viking initiates study to evaluate dual GLP-1/GIP receptor agonist VK2735

All caught up?

See all news

New: Directory

Discover global suppliers of specialist bariatric services, treatments, products, and medical equipment.

Browse directory

Events

Headlines

Research

Industry

All caught up?

New: Directory

Discover global suppliers of specialist bariatric services, treatments, products, and medical equipment.

Events

(See all)

4th London International Bariatric Surgery Symposium

European Congress on Obesity 2023

BOMSS Annual Scientific Meeting 2023

7th Gulf Obesity Surgery Society International Conference

SOFFCO-MM 2023

XXVI IFSO WORLD CONGRESS 2023

IBC Oxford Congress 2023

ASMBS 2023 Annual Meeting

Tweets

Weekly Digest

Get a round-up of the main headlines from Bariatric News, directly to your inbox each week.

Get in touch!
Email: info@bariatricnews.net